- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02363920
Short Term Physiological Effects of Nasal High Flow Oxygen on Respiratory Mechanics
Short Term Physiological Effects of Nasal High Oxygen Flow vs Low Oxygen Flow and Noninvasive Ventilation (NIV) on Respiratory Mechanics
Nasal High Oxygen Flow (HOF) has been demonstrated to reduce the re-intubation rate in hypoxic patients and ameliorate breathing pattern in hypercapnic patients.
The aim of this study is to better understand the physiological mechanism underlying these results, assessing the respiratory mechanics in stable hypercapnic COPD patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subjects. 10 in-patients with stable COPD and chronic hypercapnic respiratory failure with no history of neurological or chronic cardiac disease will be recruited. They need to be in a phase of clinical stability and were for a short period of rehabilitation. Patients with X-ray evidence of pulmonary edema or congestion and pulmonary infiltrate will be excluded from the study. Written consent will be obtained from all subjects, and the protocol will be approved by the Ethics Committee.
Measurements. Static and dynamic lung volumes assessed by body plethysmography (MasterLab-Jaeger, Hochberg, Germany).
Flow measured with a pneumotachograph (Screenmate Box 0586, Jaeger GmbH, Hochberg, Germany), connected to a rigid mouthpiece.
Airway pressure measured through tubing inserted in the mouthpiece and connected to a differential pressure transducer (Honeywell 300 cm H2O, Freeport, IL, USA). VT obtained by integration of the flow signal. The inspiratory (TI), expiratory (TE) and total breathing cycle (TTOT) duration, respiratory frequency (RR), and duty cycle (TI/TTOT) calculated as average values of 10 consecutive breaths, after 5 minutes of breathing.
Baseline from peak changes in esophageal (Pes), gastric (Pga), and transdiaphragmatic (Pdi) pressures measured using the balloon-catheter technique. Pressure at the airway opening (Paw) measured via a side port.
Respiratory mechanics will be assessed using Mead and Wittenberger's technique. Inspiratory pulmonary resistance (R,L) and elastance (E,L) calculated by fitting the equation of motion of a single-compartment model using multilinear regression.
Dynamic PEEPi (PEEPi,dyn) will be measured according to Appendini et al. The pressure time integrals of the diaphragm and the other inspiratory muscles calculated per breath (PTPdi/b and PTPes/b, respectively) and per minute (PTPdi/min and PTPes/min).
Subjective ratings of dyspnea assessed during the various trials using Borg's scale.
Arterial blood gases (ABGs) measured in samples taken from the radial artery (ABL 550 Radiometer, Copenhagen, Denmark).
The above mentioned variables, excluding arterial blood gases recorded after 15 minutes of spontaneous breathing. At the end of this part of the study, the patients will undergo a randomized 30' trial of: 1) non-invasive mechanical ventilation (NIMV) through a nose mask for 20 minutes while they were in a sitting position. The following pressures will be used: 14 cmH2O of inspiratory aid and 4 cmH2O of expiratory-positive airway pressure. 2) HOF at the flow of 20 L/min 3) HOF at the flow of 30 L/min ECG, SaO2 will be continuosly recorded All signals collected using a personal computer equipped with an A/D board, and stored at a sampling rate of 100 Hz. The mean value of each physiological variable during the 5 minutes of recording used for analyses. Results presented as mean + standard deviation (SD). Differences between physiological parameters recorded in the 3 settings will be analysed by paired Student's T-test. Pearson's coefficient will be used to calculate to assess correlation between variables. A p value <0.05 chosen as the threshold of statistical significance.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Bologna, Italy, 40138
- san'Orsola Malpighi Hospital, Bologna ITALY
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- COPD patients
- Chronic hypercapnic respiratory failure (pH>7.34 and PaCO2>45 mmHg)
Exclusion Criteria:
- Cancer
- Neurological and cardiac disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: spontaneous breathing trial
the patients will be asked to breathe spontaneously using their acutal low oxygen flow
|
the addition of high oxygen flow to patients breathing spontaneously
the addition of a ventilatory support delivered with a oro-nasal interface
|
Active Comparator: HOF20
the patients will be asked to breathe with HOF of 20 L/min
|
the addition of high oxygen flow to patients breathing spontaneously
the addition of a ventilatory support delivered with a oro-nasal interface
|
Active Comparator: HOF30
the patients will be asked to breathe with HOF of 30 L/min
|
the addition of high oxygen flow to patients breathing spontaneously
the addition of a ventilatory support delivered with a oro-nasal interface
|
Active Comparator: noninvasive mechanical ventilation (NIV)
the patients will be asked to breathe with the support of a ventilator via a oro-nasal interface
|
the addition of high oxygen flow to patients breathing spontaneously
the addition of a ventilatory support delivered with a oro-nasal interface
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
recording of respiratory mechanics
Time Frame: 30 minutes per arm
|
Respiratory mechanics will be assessed using Mead and Wittenberger's technique.
|
30 minutes per arm
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
dyspnea score
Time Frame: 30 minutes per arm
|
dyspnea will be recorded using the Borg scale that is a numeric scale where 0 is no dyspnea and 10 the maximal dyspnea that a patient can imagine
|
30 minutes per arm
|
Collaborators and Investigators
Investigators
- Principal Investigator: stefano nava, md, sant'orsola malpighi hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 402015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Not yet recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
University Hospital, BrestRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Baylor Research InstituteNot yet recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
Clinical Trials on HOF
-
Wayne State UniversityUnknownBipolar Disorder I | Bipolar Disorder II | Bipolar Affective Disorder, Currently in RemissionUnited States
-
Stichting ReadeDr. C.J. Vaillant Fonds; W.M. de Hoop Stichting; Ars Donandi / Yske Walther fonds and other collaboratorsEnrolling by invitationSpinal Cord InjuriesNetherlands
-
University of BernCompletedHealthy | Stress | Blood Pressure | Cold ExposureSwitzerland
-
NYU Langone HealthCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Radboud University Medical Center; Bernhoven HospitalCompleted
-
Radboud University Medical CenterCompleted
-
Lidds ABUppsala UniversityCompletedProstate CancerFinland, Sweden
-
Lidds ABCompleted